Journal of Acute Disease (Jan 2022)

Goal-directed fluid therapy in gastrointestinal cancer surgery: A prospective randomized study

  • Duygu Akyol,
  • Zafer Cukurova,
  • Evrim Kucur Tulubas,
  • Güneş Özlem Yıldız,
  • Mehmet Süleyman Sabaz

DOI
https://doi.org/10.4103/2221-6189.342661
Journal volume & issue
Vol. 11, no. 2
pp. 52 – 58

Abstract

Read online

Objective: To investigate the effects of perioperative goal-directed fluid therapy (GDFT) on intraoperative fluid balance, postoperative morbidity, and mortality. Methods: This is a prospective randomized study, and 90 patients who underwent elective open gastrointestinal cancer surgery between April 2017 and May 2018 were included. Patients were randomized into 2 groups that received liberal fluid therapy (the LFT group, n=45) and goal-directed fluid therapy (the GDFT group, n=45). Patients’ Colorectal Physiologic and Operative Severity Score for the enUmeration of Mortality and Morbidity (CR-POSSUM) physiological score, Charlson Comorbidity Index (CCI), perioperative vasopressor and inotrope use, postoperative AKIN classification, postoperative intensive care unit (ICU) hospitalization, hospital stay, and 30-day mortality were recorded. Results: The volume of crystalloid used perioperatively and the total volume of fluid were significantly lower in the GDFT group compared to the LFT group (P0.05). Conclusion: Although GDFT was demonstrated to be a good alternative method to LFT in open gastrointestinal cancer surgery, and it can prevent perioperative fluid overload, and the postoperative results are comparable in the two groups.

Keywords